Comparison of the urinary glucose excretion contributions of SGLT2 and SGLT1: A quantitative systems pharmacology analysis in healthy individuals and patients with type 2 diabetes treated with SGLT2 inhibitors

Urinary Glucose ◽

Review for "Urinary glucose excretion contributions of SGLT2 vs . SGLT1 transporters: a quantitative systems pharmacology analysis in healthy and T2DM subjects administered SGLT2 inhibitors"

10.1111/dom.13858/v1/review2 ◽

2019 ◽

Author(s):

Iouri Bachmakov

Keyword(s):

Sglt2 Inhibitors ◽

Systems Pharmacology ◽

Urinary Glucose ◽

Author response for "Urinary glucose excretion contributions of SGLT2 vs . SGLT1 transporters: a quantitative systems pharmacology analysis in healthy and T2DM subjects administered SGLT2 inhibitors"

10.1111/dom.13858/v2/response1 ◽

2019 ◽

Author(s):

Tatiana Yakovleva ◽

Victor Sokolov ◽

Lulu Chu ◽

Weifeng Tang ◽

Peter J. Greasley ◽

...

Keyword(s):

Sglt2 Inhibitors ◽

Author Response ◽

Systems Pharmacology ◽

Urinary Glucose ◽

Review for "Urinary glucose excretion contributions of SGLT2 vs . SGLT1 transporters: a quantitative systems pharmacology analysis in healthy and T2DM subjects administered SGLT2 inhibitors"

10.1111/dom.13858/v1/review3 ◽

2019 ◽

Keyword(s):

Sglt2 Inhibitors ◽

Systems Pharmacology ◽

Urinary Glucose ◽

Review for "Urinary glucose excretion contributions of SGLT2 vs . SGLT1 transporters: a quantitative systems pharmacology analysis in healthy and T2DM subjects administered SGLT2 inhibitors"

10.1111/dom.13858/v1/review1 ◽

2019 ◽

Author(s):

Parloop Bhatt

Keyword(s):

Sglt2 Inhibitors ◽

Systems Pharmacology ◽

Urinary Glucose ◽

Decision letter for "Urinary glucose excretion contributions of SGLT2 vs . SGLT1 transporters: a quantitative systems pharmacology analysis in healthy and T2DM subjects administered SGLT2 inhibitors"

10.1111/dom.13858/v2/decision1 ◽

2019 ◽

Keyword(s):

Sglt2 Inhibitors ◽

Systems Pharmacology ◽

Urinary Glucose ◽

Decision letter for "Urinary glucose excretion contributions of SGLT2 vs . SGLT1 transporters: a quantitative systems pharmacology analysis in healthy and T2DM subjects administered SGLT2 inhibitors"

10.1111/dom.13858/v1/decision1 ◽

2019 ◽

Keyword(s):

Sglt2 Inhibitors ◽

Systems Pharmacology ◽

Urinary Glucose ◽

Review for "Urinary glucose excretion contributions of SGLT2 vs . SGLT1 transporters: a quantitative systems pharmacology analysis in healthy and T2DM subjects administered SGLT2 inhibitors"

10.1111/dom.13858/v2/review1 ◽

2019 ◽

Keyword(s):

Sglt2 Inhibitors ◽

Systems Pharmacology ◽

Urinary Glucose ◽

Morning Spot Urine Glucose-to-Creatinine Ratios Predict Overnight Urinary Glucose Excretion in Patients With Type 2 Diabetes

Annals of Laboratory Medicine ◽

10.3343/alm.2017.37.1.9 ◽

2017 ◽

Vol 37 (1) ◽

pp. 9-17 ◽

Cited By ~ 4

Author(s):

So Ra Kim ◽

Yong-ho Lee ◽

Sang-Guk Lee ◽

Sun Hee Lee ◽

Eun Seok Kang ◽

...

Keyword(s):

Type 2 Diabetes ◽

Urine Glucose ◽

Spot Urine ◽

Urinary Glucose ◽

LX4211 Therapy Reduces Postprandial Glucose Levels in Patients With Type 2 Diabetes Mellitus and Renal Impairment Despite Low Urinary Glucose Excretion

Clinical Therapeutics ◽

10.1016/j.clinthera.2014.10.026 ◽

2015 ◽

Vol 37 (1) ◽

pp. 71-82.e12 ◽

Cited By ~ 25

Author(s):

Brian Zambrowicz ◽

Pablo Lapuerta ◽

Paul Strumph ◽

Phillip Banks ◽

Alan Wilson ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Renal Impairment ◽

Postprandial Glucose ◽

Glucose Levels ◽

Urinary Glucose ◽

Association of serum fibroblast growth factor 21 and urinary glucose excretion in hospitalized patients with type 2 diabetes

Journal of Diabetes and its Complications ◽

10.1016/j.jdiacomp.2020.107750 ◽

2021 ◽

Vol 35 (1) ◽

pp. 107750

Author(s):

Rui Zhang ◽

Xiaoling Cai ◽

Yongrui Du ◽

Liu Liu ◽

Xueyao Han ◽

...

Keyword(s):

Type 2 Diabetes ◽

Growth Factor ◽

Fibroblast Growth Factor ◽

Hospitalized Patients ◽

Fibroblast Growth Factor 21 ◽

Fibroblast Growth ◽

Urinary Glucose ◽